Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms
    Cochrane Systematic Reviews, 12-Jul-2022
  • Antipsychotics for treatment of delirium in hospitalised non‐ICU patients
    Cochrane Systematic Reviews, 18-Jun-2018
  • Antipyretic measures for treating fever in malaria
    Cochrane Systematic Reviews, 12-Sep-2012
  • Antiretroviral interventions for preventing breast milk transmission of HIV
    Cochrane Systematic Reviews, 28-Sep-2014
  • Antiretroviral post‐exposure prophylaxis (PEP) for occupational HIV exposure
    Cochrane Systematic Reviews, 24-Jan-2007
  • Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals
    Cochrane Systematic Reviews, 10-Nov-2012
  • Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy
    Cochrane Systematic Reviews, 19-Jan-2011
  • Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women
    Cochrane Systematic Reviews, 5-May-2010
  • Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
    Cochrane Systematic Reviews, 26-Mar-2013
  • Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection
    Cochrane Systematic Reviews, 13-Jun-2011
  • Anti‐seizure medications for Lennox‐Gastaut syndrome
    Cochrane Systematic Reviews, 7-Apr-2021
  • Antiseptics for burns
    Cochrane Systematic Reviews, 28-Jun-2017
  • Antispasmodics for labour
    Cochrane Systematic Reviews, 5-Jun-2013
  • Anti‐spasticity agents for multiple sclerosis
    Cochrane Systematic Reviews, 20-Oct-2003
  • Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants
    Cochrane Systematic Reviews, 15-Apr-2009
  • Antistreptococcal interventions for guttate and chronic plaque psoriasis
    Cochrane Systematic Reviews, 5-Mar-2019
  • Antistreptococcal interventions for guttate and chronic plaque psoriasis
    Cochrane Systematic Reviews, 6-Mar-2019
  • Antithrombin for respiratory distress syndrome in preterm infants
    Cochrane Systematic Reviews, 18-Oct-2006
  • Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants
    Cochrane Systematic Reviews, 21-Mar-2016
  • Antithrombin III for critically ill patients
    Cochrane Systematic Reviews, 9-Feb-2016

Login or Subscribe


Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More